CRISPR in Drug Discovery 2023

Registrations are closed

The fifth CRISPR in Drug Discovery: From Targets to Therapeutics meeting

Applications of genome engineering, especially CRISPR/Cas9, continue to evolve rapidly. This meeting aims to bring together the research community in the field of genome engineering, particularly those with interest in drug discovery and how technologies are advancing this field. The meeting will focus on developing technology ranging from large scale CRISPR based functional genomics studies, developing advanced cellular and in vivo disease models for target validation, and its pioneering applications in therapeutic genome editing.  

Join scientists from academia, pharma, biotech, and CRO’s to hear talks given by speakers at the cutting edge of genome engineering, network at the exhibition, and gain strategic insights into solutions for increasing the success of drug discovery and development.

Come meet us!

Come our scientific experts Dr. Tamas Gerecsei and Anabel Migenda Herranz to find out about our cutting-edge genome engineering technology. You'll discover how FluidFM technology enables fast and efficient CRISPR genome engineering through direct intranuclear injection!

Date & Time
Tuesday February 07, 2023
Start - 8:00 AM (Europe/Zurich)
Wednesday February 08, 2023
End - 3:30 PM (Europe/Zurich)

The King's Centre

Osney Mead
United Kingdom
--The King's Centre--
Get the direction

ELRIG (UK) Limited

--ELRIG (UK) Limited--

Find out what people see and say about this event, and join the conversation.